Navigation Links
Genstar Names Michael Hurt to Its Strategic Advisory Board

CEO of Former Portfolio Company is a Proven Leader at Driving Growth

SAN FRANCISCO, Sept. 5 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of life sciences and healthcare services, industrial technology, business services and software, today announced the appointment of Michael L. Hurt to the firm's Strategic Advisory Board (SAB). The addition of Mr. Hurt, CEO of Altra Industrial Motion (Nasdaq: AIMC), a former Genstar portfolio company, increases to 18 the number of influential senior executives who are current or former leaders of major corporations and have joined the firm in this advisory capacity.

"I have known Mike for more than 15 years since my first LBO of the company he ran and he is a multi-talented executive who repeatedly has driven growth at the businesses he has overseen," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "The Genstar team has become familiar with Mike's ability to successfully lead organizations, most recently as head of our portfolio company Altra Holdings where he achieved spectacular growth and tripled operating profit in less than three years. We are very pleased that he will now provide the skills he has obtained over nearly 40 years of working with industrial technology businesses to our management teams as we grow our investments."

Mr. Hurt is currently CEO of Altra Industrial Motion, which designs, produces, and distributes a wide range of mechanical power transmission products that serve a variety of applications. Prior to leading Altra, he worked with Genstar as an advisor in the Industrial Technology area after retiring as the President and CEO of TB Wood's Corporation in November 2003. In addition to Altra, Mr. Hurt spent thirteen years at TB Wood's and 23 years with the Torrington Company, a division of Ingersoll Rand.

A graduate of Clemson University with a BSME degree in mechanical engineering, Mr. Hurt holds an MBA degree from Clemson-Furman University. He is a registered professional engineer.

The Genstar SAB includes executives from such leading companies as Pharmacia & Upjohn, Inc., CNA Insurance Companies, ITT Corporation, Deere & Co., Axia Health Management, MedImmune, Inc., Wild Oats Markets, WellPoint, Inc., NEN Life Science Products, and ICOS Corporation.

About Genstar Capital, LLC

Based in San Francisco, Genstar Capital ( is a private equity investment firm that makes leveraged investments in quality middle- market companies. Genstar Capital works in partnership with management to transform its portfolio companies into industry-leading businesses. With more than $3 billion of committed capital under management and significant experience investing in businesses, Genstar focuses on selected segments of life science and healthcare services, industrial technology, business services and software services.

SOURCE Genstar Capital, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Wisconsin IT association names Gee president, CEO
2. Quintessence Biosciences names new president
3. CDW names VP to handle Berbee merger
4. NimbleGen names CFO with capital-raising past
5. Cisco names Berbee a top partner of 2005
6. Cisco names Inacom most innovative partner
7. UW-Madison medical school names new dean
8. GE Healthcare names new CEO
9. Bruker AXS names new leadership
10. Sonic Foundry names new senior vice president
11. MyWeather names new president, marketing officer
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
Breaking Biology News(10 mins):